Insurers, FDA team up to find problem drugs

RSS

Wall Street Journal (subscription required), April 15, 2008

WellPoint Inc. is collaborating with the Food and Drug Administration to launch one of the first real-time drug-surveillance systems. Starting in 2009, Wellpoint will systematically scan the medical information of more than half of its 35 million members to look for hidden patterns or jumps in medical problems that might be linked to certain medication or combination of drugs. The drug-safety monitoring system currently used by the FDA has been criticized for spotty, slow and passive.

Full Story

A pinpoint beam strays invisibly, harming instead of healing

Stereotactic radiosurgery, or SRS, is one of the fastest-growing radiation therapies, a technological innovation designed to target tiny tumors and other anomalies affecting the brain or spinal cord, while...

New safety program to monitor Medicare drug use

Federal health officials will begin monitoring prescription drug usage by Medicare participants in an effort to identify potential safety problems. New regulations will enable the FDA, states and academic...

Reports of deaths linked to blood-thinner heparin triple

The number of reports of deaths linked to all versions of the blood thinner heparin have tripled, according to a report released by the U.S. Food and Drug Administration. The FDA said there are now 62 reports...

Webcast: OPPE Best Practices Series: When OPPE leads to FPPE

go to complete list